Clinical trial
Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent…
NCT00245102 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00245102 |
|---|---|
| Title | Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma |
| Official title | A Multicenter Phase II Study of Sorafenib (BAY43-9006) in Non-GIST Sarcomas |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Leiomyosarcoma, Adult Malignant Fibrous Histiocytoma, Adult Neurofibrosarcoma, Adult Synovial Sarcoma, Ovarian Sarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Uterine Sarcoma, Stage III Adult Soft Tissue Sarcoma and 5 more |
| Intervention type | Drug |
| Interventions | sorafenib tosylate |
| Enrollment | 147 |
| Start date | Sep 1, 2005 |
| Primary completion | Mar 1, 2011 |
| Completion | Mar 1, 2011 |
| First posted | Oct 27, 2005 |
| Last update posted | May 23, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: